A study in the PC-3 PC cell line, which has a CRPC phenotype, demonstrated that Tofacitinib inhibited IL-7-dependent phosphorylation of Stat5 and IL-7-induced invasion of PC cells [174]. Here, STAT5A is linked to pachyonychia congenita.